SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001630575-20-000003
Filing Date
2020-12-23
Accepted
2020-12-22 18:17:36
Documents
1
Effectiveness Date
2020-12-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8538
  Complete submission text file 0001630575-20-000003.txt   9599
Mailing Address 2929 CAMPUS DRIVE SUITE 405 SAN MATEO CA 94403
Business Address 2929 CAMPUS DRIVE SUITE 405 SAN MATEO CA 94403 858-344-7499
Vivace Therapeutics, Inc. (Filer) CIK: 0001630575 (see all company filings)

IRS No.: 320452793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-384119 | Film No.: 201409285